Innovent Biologics jumps most in 3 weeks on robust product revenue growth
05/08/2026 02:52
BUZZ-Innovent Biologics jumps most in 3 weeks on robust product revenue growth ** Shares of Innovent Biologics Inc 1801.HK jump 6.3% to HK$92.2, on track for the biggest one-day pct gain since July 15
** Stock touches the highest level since July 24 in the second session of gain
** The innovative medicine developer and producer says its first half 2026 product revenue exceeds 8.2 bln yuan ($1.21 bln), up over 55% y/y, of which total revenue for the second quarter is up 60% y/y to over 4.3 bln yuan
** YTD, stock up 18%, Hang Seng Biotech Index .HSBIO up 0.6%
($1 = 6.7532 Chinese yuan renminbi)
(Reporting by Donny Kwok)
Recent news on China Renaissance Holdings
See all newsChina Renaissance H1 revenue falls 3% as management fees drop
Innovent Biologics jumps most in 3 weeks on robust product revenue growth
Brief: China Renaissance Places $12 Million Fiduciary Deposit Through LGT On July 20, 2026
Media: China Renaissance hires Huatai's Liu as Hong Kong banking head - Bloomberg News
Brief: China Renaissance Subscribes For Wealth Management Product At Aggregate Subscription Amount Of $30 Million